Fig. 6From: Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in miceGal-9-ERC-based therapy modulated T helper cell percentages. As observed in vitro experiment, and transcription factor expression differences in allografts, we would like to further evaluate Gal-9-ERC-based therapy in modulating T helper cells. Splenocytes were harvested on POD8 and stained for FACS. a, b Representative dot plots of Th1 (CD4+IFN-γ+) and Th17 (CD4+IL-17+) cells. c, d Percentage of Th1 (CD4+IFN-γ+) and Th17 (CD4+IL-17+) cells (n = 6). Differences among groups were assessed by using one-way analysis of variance (ANOVA). *p < 0.05, **p < 0.01. Abbreviations: ERC, endometrial regenerative cell; Gal-9-ERC, Galectin-9 high-expression ERC; Rapa, rapamycinBack to article page